golodirsen

Sarepta competitor files with FDA for Duchenne drug
Seeking Alpha
Wed, 10/2/19 - 12:12 pm
Sarepta Therapeutics
NS Pharma
golodirsen
FDA
Duchenne Muscular Dystrophy
Sarepta to seek FDA approval for its second Duchenne’s drug by year’s end
Stat
Mon, 03/12/18 - 09:37 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
golodirsen
Exondys 51
Sarepta halts its golodirsen Duchenne MD study in UK after patient experiences adverse event
Endpoints
Fri, 02/9/18 - 09:35 am
Sarepta Therapeutics
golodirsen
Duchenne Muscular Dystrophy
UK
Sarepta readies FDA pitch after a small study spotlights 1% dystrophin add for golodirsen in Duchenne MD
Endpoints
Wed, 09/6/17 - 09:52 am
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
golodirsen